Literature DB >> 3567364

Relaxant effects of vasoactive intestinal peptide and peptide histidine isoleucine in human and bovine pulmonary arteries.

B Greenberg, K Rhoden, P J Barnes.   

Abstract

We studied the functional effects of vasoactive intestinal peptide (VIP) and the structurally related peptide histidine isoleucine (PHI) in segments of bovine and human intrapulmonary artery. In both species, VIP caused nearly complete relaxation of precontracted vessel segments. The EC50 was 1.3 +/- 0.3 X 10(-9) M (mean +/- SD) in bovine and 3.4 +/- 0.4 X 10(-9) M in human pulmonary artery. The response to VIP was not endothelium-dependent and it was not affected by either adrenergic and cholinergic blockade or by cyclooxygenase inhibition. PHI also relaxed human and bovine vessels but this related peptide was significantly less effective than VIP. We conclude that VIP is a potent inhibitor of bovine and human pulmonary artery, which appears to act directly on vascular smooth muscle. These data support the concept that VIP may be a neurotransmitter which modulates pulmonary artery tone in both man and cow.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3567364     DOI: 10.1159/000158670

Source DB:  PubMed          Journal:  Blood Vessels        ISSN: 0303-6847


  10 in total

1.  Calcitonin gene-related peptide (CGRP) is a potent non-endothelium-dependent inhibitor of coronary vasomotor tone.

Authors:  B Greenberg; K Rhoden; P Barnes
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

2.  Regulatory peptides in the respiratory system.

Authors:  P J Barnes
Journal:  Experientia       Date:  1987-07-15

3.  Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension.

Authors:  Ventzislav Petkov; Wilhelm Mosgoeller; Rolf Ziesche; Markus Raderer; Leopold Stiebellehner; Karin Vonbank; Georg-Christian Funk; Gerhard Hamilton; Clemens Novotny; Bernhard Burian; Lutz-Henning Block
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

4.  Maintenance of functional activity of human pulmonary arteries after cryopreservation.

Authors:  P Ellis; E Müller-Schweinitzer
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

5.  Adenoviral transfer of vasoactive intestinal peptide (VIP) gene inhibits rat aortic and pulmonary artery smooth muscle cell proliferation.

Authors:  Rose-Claire St Hilaire; Philip J Kadowitz; James R Jeter
Journal:  Peptides       Date:  2009-08-19       Impact factor: 3.750

6.  Effects of neuropeptide Y and vasoactive intestinal peptide on human venous smooth muscle in vivo.

Authors:  M Wolzt; W Gerschlager; B Zweytick; B Jilma; H Riemer; K Sertl; H G Eichler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

7.  Modulation of cholinergic neural bronchoconstriction by endogenous nitric oxide and vasoactive intestinal peptide in human airways in vitro.

Authors:  J K Ward; M G Belvisi; A J Fox; M Miura; S Tadjkarimi; M H Yacoub; P J Barnes
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

8.  Vasoactive intestinal Peptide inhaled agonists: potential role in respiratory therapeutics.

Authors:  Ag Mathioudakis; V Chatzimavridou-Grigoriadou; E Evangelopoulou; Ga Mathioudakis
Journal:  Hippokratia       Date:  2013-01       Impact factor: 0.471

9.  Evidence for the involvement of cGMP in neural bronchodilator responses in humal trachea.

Authors:  J K Ward; P J Barnes; S Tadjkarimi; M H Yacoub; M G Belvisi
Journal:  J Physiol       Date:  1995-03-01       Impact factor: 5.182

10.  A study of nerves containing peptides in the pulmonary vasculature of healthy infants and children and of those with pulmonary hypertension.

Authors:  K M Allen; J Wharton; J M Polak; S G Haworth
Journal:  Br Heart J       Date:  1989-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.